Subscribe
Launches
4 min read

Fi Puts Its Dog Tracker on Starlink Satellites, Betting Connectivity Is the Moat

Fi launched Ultra, the first consumer dog tracker on T-Satellite with Starlink, keeping dogs locatable past cellular range. The satellite feature is really a subscription play, and the Whistle shutdown shows the lock-in risk baked into pet-wearable memberships.

Written by
The Underbite
Published on
July 8, 2026
Fi Puts Its Dog Tracker on Starlink Satellites, Betting Connectivity Is the Moat

Fi Ultra puts dog tracking on Starlink satellites

Fi launched Ultra on July 8, positioned as the first consumer dog tracker to use T-Satellite with Starlink, the low-earth-orbit network that turns satellites into cell towers in space. When a dog moves beyond LTE range, the collar switches to satellite automatically, so location updates keep coming in the backcountry or past a rural fence line.

The device pairs that with dual-band GPS, multi-day battery, and Fi Callback, a sound-and-vibration recall feature the company is careful to note uses no electric shock.

Pricing is where the model shows. New members pay $199 for the device plus a $189 annual membership. Existing members can move to Ultra for a $299 flat fee. It's on sale now at fitracking.com and snaps onto the collars of Fi's earlier Series 3 hardware.

The satellite piece rests on infrastructure that only recently went live. T-Mobile launched T-Satellite commercially on July 23, 2025, at $10 a month, using more than 650 Starlink satellites to reach devices where towers don't. Fi is among the first to embed that capability in something other than a phone.

Connectivity is a moat, and a lock-in risk

The recurring fee is the real product. Fi sells a $189-a-year membership, and satellite coverage is the kind of feature that justifies it, deepens the reason to stay subscribed, and raises the cost of switching to a rival collar. For a hardware company, that shift from one-time device sale to durable subscription revenue is the whole game.

The numbers behind Fi point the same direction. The company has raised about $45 million, with a Series B led by Longview Asset Management, and told Fortune it expects to cross $100 million in annual recurring revenue this year. It now sells in dozens of countries and, in March, layered on an AI health product, Fi Intelligence. Ultra extends the pattern: more reasons to pay every month, fewer reasons to leave.

That logic sits inside a growing market. Pet wearables run roughly $3.8 billion in 2026 and are projected to reach $11.4 billion by 2033. Location tracking and health monitoring are the anchor use cases, and both reward whoever owns the connectivity layer.

But the category has already shown operators the downside of subscription lock-in. Fi's Austrian rival Tractive acquired Whistle in 2025 and shut the product line down, bricking thousands of devices and stranding paying customers. That episode is the cautionary counterweight to every "membership" pitch in pet tech: when the collar is useless without the service, the customer's investment is only as safe as the vendor's roadmap.

Fi is betting the moat outweighs the mistrust. Satellite is a genuine differentiator, hard to copy, and useful precisely for the adventure-dog owner most willing to pay. The question is whether that owner values coverage they may use only a handful of times a year enough to carry a second annual fee on top of the T-Satellite economics underneath it.

Whether owners pay for coverage they rarely use

The tell will be attach rate. Watch whether Ultra pulls existing Fi members up to the higher tier and brings in new buyers who weren't tracker customers before, or whether satellite reads as a premium novelty that a small slice of the base adopts.

The second signal is margin. Fi is riding on T-Mobile and SpaceX infrastructure it doesn't own, and satellite connectivity carries real per-device cost. The $189 membership has to cover that and still fund the AI features Fi keeps adding. If the satellite bill climbs faster than attach rate, the moat gets expensive.

The third is trust. The pet-wearable subscription model works only if buyers believe the service will outlast the warranty. After the Whistle shutdown, the brands that win will be the ones that make the recurring relationship feel durable, not fragile. Fi's pitch is that owning more of the stack, connectivity included, is how you earn that. The next year of renewals will show whether owners agree.

Source: Fi Launches the World's First Consumer Wearable Powered by T-Satellite With Starlink, via Business Wire

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
Vetspire Splits From Thrive, Lands a Battery Ventures Backing
Funding & M&A
4 min read

Vetspire Splits From Thrive, Lands a Battery Ventures Backing

Vetspire has spun out of Thrive Pet Healthcare's orbit with a growth investment from Battery Ventures and a new CEO, Zachary Seely. The AI-powered practice management platform, used by more than 800 veterinary hospitals and clinics, will operate independently while Thrive remains a customer. The deal tests whether AI-native vet software can draw institutional capital without a strategic parent underwriting it.

Read article
Read article
PetMeds Revenue Falls 20% as Takeover Fight Drags On
Earnings
6 min read

PetMeds Revenue Falls 20% as Takeover Fight Drags On

PetMeds' first-quarter revenue fell 19.9% to $41.0 million and cash reserves dropped to $13.1 million, even as the company narrowed its net loss to $6.1 million from $34.2 million a year earlier. The results land as an unsolicited $3-a-share buyout offer from SilverCape Investments remains on the table and a $37 million sale-leaseback of its headquarters awaits closing.

Read article
Read article
FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North
Regulatory
4 min read

FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North

The FDA granted Zoetis an emergency use authorization for Simparica Trio to treat New World screwworm in dogs, the first product cleared specifically for the threat. Texas has already begun requiring treatment before dogs cross certain lines, putting boarding facilities, transporters, and border-state vet practices under a new compliance mandate.

Read article
View all articles